Search Results 41-50 of 10608 for cannabis
Cannabis Cannabinoid Res. 2024 Dec; 9 (6):e1556-e1564 Epub 2024 July 17. View PubMed; Baral B, Suleiman R, Fazer-Posorske CA, Ma DJ, McGarrah PW, Thome SD ...
Cannabis for the Treatment of Crohn's Disease and Ulcerative Colitis: Evidence From Cochrane Reviews. Inflamm Bowel Dis. 2020 Mar 4; 26 (4):502-509. View ...
Cannabis products have been reported to make seizures worse. The FDA doesn't currently regulate herbal products. Herbs can interact with anti-seizure medicines, ...
Coughing more than usual may be a sign your body is starting to heal. Tobacco smoke paralyzes and destroys some of the tiny hair-like structures in the ...
Use of other cannabis products within 30 days prior to registration. History of allergy to cannabis products. Crossover Re-Registration – Inclusion Criteria ...
Cannabis; Carbamazepine; Carbidopa; Ceritinib; Cetirizine; Clobazam; Clonazepam; Codeine; Conivaptan; Daridorexant; Dexmedetomidine; Dihydrocodeine; Doxylamine ...
Association between cannabis and psychosis: Epidemiologic evidence. Biological Psychiatry. 2016;79:549. Quick facts on the risks of e-cigarettes for kids ...
Medical cannabis (adult). Mayo Clinic; 2019. Niederhuber JE, et al., eds. Cancer-related pain. In: Abeloff's Clinical Oncology. 6th ed. Elsevier; 2020 ...
Bulimia nervosa; Cannabis (marijuana) use; Cholecystitis · Coronavirus disease 2019 (COVID-19) · Crohn's disease — which causes tissues in the digestive tract ...
Cannabis; Carbamazepine; Carbidopa; Carbinoxamine; Ceritinib; Cetirizine; Clobazam; Clonazepam; Cobicistat; Codeine; Conivaptan; Daridorexant; Dexmedetomidine ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your Annual Fund gift can drive advancements in cancer care.